Re: AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer: Editorial comment

Samir S. Taneja

doi:10.1016/j.juro.2014.11.066

Re: AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer: Editorial comment

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	538-540
Number of pages	3
Journal	Journal of Urology
Volume	193
Issue number	2
DOIs	https://doi.org/10.1016/j.juro.2014.11.066
State	Published - Feb 1 2015

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.juro.2014.11.066

Cite this

@article{9f16093d65b8483cbcdb5d50f54b3d43,

title = "Re: AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer: Editorial comment",

author = "Taneja, {Samir S.}",

year = "2015",

month = feb,

day = "1",

doi = "10.1016/j.juro.2014.11.066",

language = "English (US)",

volume = "193",

pages = "538--540",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Re

T2 - AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer: Editorial comment

AU - Taneja, Samir S.

PY - 2015/2/1

Y1 - 2015/2/1

UR - http://www.scopus.com/inward/record.url?scp=84920682074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920682074&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2014.11.066

DO - 10.1016/j.juro.2014.11.066

M3 - Comment/debate

C2 - 25617272

AN - SCOPUS:84920682074

SN - 0022-5347

VL - 193

SP - 538

EP - 540

JO - Journal of Urology

JF - Journal of Urology

IS - 2

ER -

Re: AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer: Editorial comment

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this